GP-Act III Acquisition Corp. (NASDAQ:GPAT) Short Interest Update

GP-Act III Acquisition Corp. (NASDAQ:GPAT – Get Free Report) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,499 shares, a decrease of 63.9% from the April 15th total of 4,148 shares. Based on an average daily trading volume, of 174,496 shares, the short-interest ratio is currently 0.0 days.

GP-Act III Acquisition Trading Down 0.2%

NASDAQ:GPAT traded down $0.02 during mid-day trading on Friday, hitting $10.82. The company had a trading volume of 430 shares, compared to its average volume of 151,044. The business has a fifty day simple moving average of $10.84 and a 200-day simple moving average of $10.75. GP-Act III Acquisition has a 1 year low of $10.42 and a 1 year high of $11.00.

Get GP-Act III Acquisition alerts:

GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in GPAT. Longfellow Investment Management Co. LLC purchased a new position in GP-Act III Acquisition in the third quarter valued at about $83,000. Bank of America Corp DE acquired a new stake in shares of GP-Act III Acquisition during the third quarter valued at about $85,000. Clear Street Group Inc. acquired a new stake in shares of GP-Act III Acquisition during the third quarter valued at about $109,000. Cannon Global Investment Management LLC acquired a new stake in shares of GP-Act III Acquisition during the third quarter valued at about $111,000. Finally, TrueMark Investments LLC acquired a new stake in shares of GP-Act III Acquisition during the third quarter valued at about $178,000.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on GP-Act III Acquisition

GP-Act III Acquisition Company Profile

(Get Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Featured Stories

• Five stocks we like better than GP-Act III Acquisition
• Viking Sails to All-Time Highs—Fundamentals Signal More to Come
• Datavalut Gains Traction: 5 Reasons to Sell Now
• TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
• The Power Grid Is Dying—Is It Time to Buy Its Replacement?

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.